Galanthamine hydrobromide 8mg orally disintegrating tablets (YJ code: 1190019F5015, standard: 8mg 1 tablet) is a generic formulation containing Galantamine hydrobromide, used to treat mild to moderate dementia symptoms associated with Alzheimer’s disease.
Galanthamine hydrobromide 8mg orally disintegrating tablets
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).